Skip to main content Skip to navigation
WSU News pharmaceutical

Visionary biochemist to receive top WSU alumni award

PULLMAN, Wash. – Biochemist James A. Wells, a pioneering engineer of proteins, antibodies and small molecules that target cell sites to thwart disease and enhance drug therapies, will receive the Regents’ Distinguished Alumnus Award at 3:45 p.m. Wednesday, Jan. 25, in the CUB auditorium at Washington State University. » More …

WSU partners to develop new anti-inflammatory drug

By Scott Weybright, College of Agricultural, Human & Natural Resource Sciences

David-GangPULLMAN, Wash. – Work on a new anti-inflammatory drug developed from the medicinal/spice plant turmeric recently received funding from a $225,000 grant from the National Institutes of Health National Center for Complementary and Integrative Health (NIH-NCCIH). » More …

Researchers discover new role for protein in cell division

By Lori Maricle, College of Pharmacy

David-Liu-webSPOKANE, Wash. – Pharmaceutical sciences researchers at Washington State University have discovered a protein’s previously unknown role in cell division. » More …

Vet Med offers clinical trial for dogs with cancer

 

 

PULLMAN – WSU’s College of Veterinary Medicine is offering a financial incentive to pet owners whose dogs participate in a clinical trial regarding B cell lymphoma, a type of blood cell cancer.

 

Artemisinin is a drug derived from the plant Artemisia annua. It has been traditionally used by Chinese herbalists in the treatment of skin diseases and malaria. In addition to its well-known antimalarial properties, the drug has recently aroused interest as an anticancer drug. 

 

In the laboratory, the drug causes cancer cell death and changes that could sensitize cancers making them more susceptible to common chemotherapy … » More …